Partial loss of genes might open therapeutic window

Abstract

The loss of genes that encode RNA splicing factors weakens cancer cells in a way that could be exploited by new approaches to treatment.

Keywords

• copy number alterations
• spliceosome
• SF3B1
• target identification and validation
• CYCLOPS genes
• cancer therapeutics